Weifan Jiang
Impact in
-
- Phytochemicals and Medicinal Plants
Papers in
-
- Cancer therapeutics and mechanisms 6
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 3
-
- Quinazolinone synthesis and applications 5
- Synthesis and biological activity 4
- Co-authors
- Zhen Wang (18 shared papers)Renke Dai (5 shared papers)Lizhen Huang (2 shared papers)Qingmei Xie (1 shared paper)Junshan Liu (1 shared paper)Jinyi Yang (1 shared paper)Yang Zhou (1 shared paper)Linsheng Zhuo (11 shared papers)
- Journals
- European Journal of Medicinal Chemistry (10 papers)Journal of Medicinal Chemistry (2 papers)Aging (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaThailandMontenegro
In The Last Decade
Weifan Jiang
33 papers receiving 466 citations
Peers
Comparison fields: 5 of 76
- Complementary and alternative medicine 47
- Toxicology 14
- Molecular Biology 252
- Pharmacology 30
- Pharmacology 42
Countries citing papers authored by Weifan Jiang
This map shows the geographic impact of Weifan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifan Jiang more than expected).
Fields of papers citing papers by Weifan Jiang
This network shows the impact of papers produced by Weifan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifan Jiang. The network helps show where Weifan Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weifan Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 126 | |
| 2 | 2019 | 48 | |
| 3 | 2022 | 42 | |
| 4 | 2016 | 31 | |
| 5 | 2018 | 22 | |
| 6 | 2022 | 20 | |
| 7 | 2020 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2022 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 7 | |
| 18 | Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans. | 2005 | 7 |
| 19 | 2024 | 6 | |
| 20 | 2023 | 6 |
About Weifan Jiang
Weifan Jiang is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Pharmacology and Pathology and Forensic Medicine, having authored 34 papers that have together received 470 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), Quinazolinone synthesis and applications (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Mechanisms and Therapy (4 papers), Synthesis and biological activity (4 papers), Ubiquitin and proteasome pathways (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (47 citations), Toxicology (14 citations), Molecular Biology (252 citations), Pharmacology (30 citations) and Pharmacology (42 citations). Weifan Jiang has collaborated with scholars based in China, Thailand and Montenegro. Frequent co-authors include Zhen Wang, Renke Dai, Lizhen Huang, Qingmei Xie, Junshan Liu, Jinyi Yang, Yang Zhou, Linsheng Zhuo, Honghua Zhang and Peng Xue. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Aging, Journal of Pharmaceutical and Biomedical Analysis and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.